Widespread HPV vaccination, screenings could prevent 99% of cervical cancer deaths
Implementing widespread HPV vaccination and regular cervical screenings could avert the more than 60 million deaths from cervical cancer among women in middle- and low-income countries. In one study, researchers found that achieving a 90% vaccination rate among girls and adding in twice-in-a-lifetime screening could decimate the incidence of cervical cancer from nearly 20 cases per 100,000 people to less than one case per 100,000 over the next century.
In the second study, researchers found that implementing the WHO’s recommendations of HPV vaccination, screening, and early access to treatment after a cervical cancer diagnosis could reduce cervical cancer deaths by a third in the next decade, and by 99% by 2120. However, the data from low- and middle-income countries are not robust, according to the authors, and could mean that the current burden of disease is much higher — making elimination more difficult to achieve.
In the second study, researchers found that implementing the WHO’s recommendations of HPV vaccination, screening, and early access to treatment after a cervical cancer diagnosis could reduce cervical cancer deaths by a third in the next decade, and by 99% by 2120. However, the data from low- and middle-income countries are not robust, according to the authors, and could mean that the current burden of disease is much higher — making elimination more difficult to achieve.
.png)
No hay comentarios:
Publicar un comentario